Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain

Bibliographic Details
Title: Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain
Authors: Susana Monge, Carmen Olmedo, Belén Alejos, María Fé Lapeña, María José Sierra, Aurora Limia
Source: Emerging Infectious Diseases, Vol 27, Iss 10, Pp 2595-2603 (2021)
Publisher Information: Centers for Disease Control and Prevention, 2021.
Publication Year: 2021
Collection: LCC:Medicine
LCC:Infectious and parasitic diseases
Subject Terms: COVID-19, coronavirus disease, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, Medicine, Infectious and parasitic diseases, RC109-216
More Details: We conducted a registries-based cohort study of long-term care facility residents >65 years of age offered vaccination against severe acute respiratory syndrome coronavirus 2 before March 10, 2021, in Spain. Risk for infection in vaccinated and nonvaccinated persons was compared with risk in the same persons in a period before the vaccination campaign, adjusted by daily-varying incidence and reproduction number. We selected 299,209 persons; 99.0% had >1 dose, 92.6% had 2 doses, and 99.8% of vaccines were Pfizer/BioNTech (BNT162b2). For vaccinated persons with no previous infection, vaccine effectiveness was 81.8% (95% CI 81.0%–82.7%), and 11.6 (95% CI 11.3–11.9) cases were prevented per 10,000 vaccinated/day. In those with previous infection, effectiveness was 56.8% (95% CI 47.1%–67.7%). In nonvaccinated residents with no previous infection, risk decreased by up to 81.4% (95% CI 73.3%–90.3%). Our results confirm vaccine effectiveness in this population and suggest indirect protection in nonvaccinated persons.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1080-6040
1080-6059
Relation: https://wwwnc.cdc.gov/eid/article/27/10/21-1184_article; https://doaj.org/toc/1080-6040; https://doaj.org/toc/1080-6059
DOI: 10.3201/eid2710.211184
Access URL: https://doaj.org/article/cbe05bedee17445f830e0e6d65ff2af3
Accession Number: edsdoj.be05bedee17445f830e0e6d65ff2af3
Database: Directory of Open Access Journals
More Details
ISSN:10806040
10806059
DOI:10.3201/eid2710.211184
Published in:Emerging Infectious Diseases
Language:English